Table 1 Characteristics of included studies
Trial (year) | Design | Country | Eyes* | Patients* | Sex (male/female) | Age (year) | Follow-up (mo) | Use of antimetabolite | |
|---|---|---|---|---|---|---|---|---|---|
Without releasable suture | Releasable suture | ||||||||
Caporossi(2009) | RCT | Italy | 33/33 | 33/33 | 21/12 | 17/16 | 61.7/66.1 | 14/14 | MMC |
Kobayashi(2011) | RCT | Japan | 25/25 | 25/25 | 12/13 | 14/11 | 69.2/69.6 | 12/12 | MMC |
Simsek (2005) | RCT | Turkey | 32/32 | 32/32 | 19/13 | 17/15 | 61.2/58.3 | 11.0/11.5 | no |
Unlu(2000) | RCT | Turkey | 20/18 | 18/17 | 9/9 | 9/8 | 60.9/61.4 | 8.3/8.1 | MMC |
Raina(1998) | RCT | India | 15/15 | 15/15 | 5/10 | 9/6 | 54.7/53.2 | 12/12 | no |
Aykan(2007) | RCT | Turkey | 27/21 | 24/19 | 16/11 | 11/10 | 59.0/61.0 | 6/6 | MMC |